(Q46666195)

24 December 2017

title

Acute lung injury and the acute respiratory distress syndrome (English)

1 reference

24 December 2017

acute respiratory distress syndrome

main subject

1 reference

1 reference

2

Michael A Matthay

1 reference

24 December 2017

author name string

Ivan W Cheng

series ordinal

1

1 reference

24 December 2017

publication date

1 October 2003

1 reference

24 December 2017

published in

Critical Care Clinics

1 reference

24 December 2017

volume

19

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

693-712

1 reference

24 December 2017

Caring for the critically ill patient. Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: can we meet the requirements of an aging population?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Acute respiratory distress in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

An expanded definition of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

The incidence of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Incidence of the adult respiratory distress syndrome in the state of Utah

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. The ARF Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Epidemiology of acute lung injury and ARDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Acute respiratory failure in the United States: incidence and 31-day survival

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Adult respiratory distress syndrome: risk with common predispositions

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Clinical risks for development of the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Clinical predictors of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Identification of patients with acute lung injury. Predictors of mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Increased mortality of older patients with acute respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

The adult respiratory distress syndrome. A report of survival and modifying factors

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Multiple organ system failure and infection in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Reduced mortality in association with the acute respiratory distress syndrome (ARDS).

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Recovery of function in survivors of the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Impairment after adult respiratory distress syndrome. An evaluation based on American Thoracic Society recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Clinical determinants of abnormalities in pulmonary functions in survivors of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Predicting the presence of pulmonary function impairment in adult respiratory distress syndrome survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Pulmonary function and health-related quality of life in a sample of long-term survivors of the acute respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Physiology of aging related to outcome in the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Recovery rate and prognosis in older persons who develop acute lung injury and the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Intact epithelial barrier function is critical for the resolution of alveolar edema in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Cytokine balance in the lungs of patients with acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Biological markers of acute lung injury: prognostic and pathogenetic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Adult respiratory distress syndrome in neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Filgrastim in patients with pneumonia and severe sepsis or septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Lung edema caused by high peak inspiratory pressures in dogs. Role of increased microvascular filtration pressure and permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Mechanisms of ventilator-induced lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Acute lung injury from mechanical ventilation at moderately high airway pressures.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Histopathologic pulmonary changes from mechanical ventilation at high peak airway pressures

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

High tidal volume ventilation produces increased lung water in oleic acid-injured rabbit lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Lung overexpansion increases pulmonary microvascular protein permeability in young lambs.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Mechanical ventilation increases microvascular permeability in oleic acid-injured lungs.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Increased microvascular permeability in dog lungs due to high peak airway pressures.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Adverse effects of large tidal volume and low PEEP in canine acid aspiration

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Intraalveolar expression of tumor necrosis factor-alpha gene during conventional and high-frequency ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Ventilator pattern influences neutrophil influx and activation in atelectasis-prone rabbit lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Multiple system organ failure. Is mechanical ventilation a contributing factor?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Hyperventilation induces release of cytokines from perfused mouse lung

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Effect of mechanical ventilation strategy on dissemination of intratracheally instilled Escherichia coli in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Adverse ventilatory strategy causes pulmonary-to-systemic translocation of endotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Lung overinflation without positive end-expiratory pressure promotes bacteremia after experimental Klebsiella pneumoniae inoculation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Pulmonary pathology of acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Established adult respiratory distress syndrome successfully treated with corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Are corticosteroids salvage therapy for refractory acute respiratory distress syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Late steroid therapy in primary acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Alveolar liquid and protein clearance from normal dog lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Beta-adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Alveolar endotoxin increases alveolar liquid clearance in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Keratinocyte growth factor reduces lung damage due to acid instillation in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Keratinocyte growth factor decreases pulmonary edema, transforming growth factor-beta and platelet-derived growth factor-BB expression, and alveolar type II cell loss in bleomycin-induced lung injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Relationships between lung computed tomographic density, gas exchange, and PEEP in acute respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Ventilation with end-expiratory pressure in acute lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Tidal ventilation at low airway pressures can augment lung injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Influence of positive end-expiratory pressure on left ventricular performance

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Mechanisms of decreased left ventricular preload during continuous positive pressure ventilation in ARDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

The hemodynamic consequences of mechanical ventilation: an evolving story

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Positive end-expiratory pressure titration in acute respiratory distress syndrome patients: impact on right ventricular outflow impedance evaluated by pulmonary artery Doppler flow velocity measurements.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Elevation of cardiac output and oxygen delivery improves outcome in septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Elevation of systemic oxygen delivery in the treatment of critically ill patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Effects of the prone position on respiratory mechanics and gas exchange during acute lung injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Effect of prone positioning on the survival of patients with acute respiratory failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Bovine surfactant therapy for patients with acute respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

High-dose corticosteroids in patients with the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2803%2900050-2

7 January 2021

10.1016/S0749-0704(03)00050-2

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017